This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tahir, S. A. Articles by Thompson, T. C. Search for Related Content PubMed PubMed Citation Articles by Tahir, S. A. Articles by Thompson, T. C.

Tumor Cell–Secreted Caveolin-1 Has Proangiogenic Activities in Prostate Cancer

¹ Scott Department of Urology, Departments of ² Molecular and Cellular Biology and ³ Radiology, Baylor College of Medicine, Houston, Texas

Requests for reprints: Timothy C. Thompson, The University of Texas M. D. Anderson Cancer Center, Department of Genitourinary Medical Oncology, Unit 1374, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-792-9955; Fax: 713-792-9956; E-mail: timthomp{at}mdanderson.org.

Key Words: caveolin-1 • uptake • angiogenesis • prostate cancer • endothelial cells

Caveolin, a major structural component of specialized plasma membrane invaginations (caveolae) that participate in diverse cellular activities, has been implicated in the pathogenesis of several human diseases, including cancer. We showed in earlier studies that caveolin-1 (cav-1) is consistently and strongly overexpressed in metastatic prostate cancer and is secreted in a biologically active form by virulent prostate cancer cells. Using both in vitro and in vivo model systems, we now present evidence supporting a proangiogenic role for cav-1 in prostate cancer development and progression. Recombinant cav-1 (rcav-1) was taken up by cav-1^–/– endothelial cells through either a lipid raft/caveolae- or clathrin-dependent mechanism, leading to specific angiogenic activities (tubule formation, cell migration, and nitric oxide production) that were mediated by rcav-1 stimulation of the PI3K-Akt-eNOS signaling module. Pathologic angiogenesis induced by cav-1 in prostate cancer–bearing mice correlated with an increased frequency, number, and size of lung metastases. We propose that in addition to its antiapoptotic role, cav-1 secreted by prostate cancer cells functions critically as a proangiogenic factor in metastatic progression of this tumor. These new insights into cav-1 function in prostate cancer may provide a base for the design of clinically applicable therapeutic strategies. [Cancer Res 2008;68(3):731–9]

This article has been cited by other articles:

				L. Li, C. Ren, G. Yang, A. A. Goltsov, K.-i. Tabata, and T. C. Thompson Caveolin-1 Promotes Autoregulatory, Akt-Mediated Induction of Cancer-Promoting Growth Factors in Prostate Cancer Cells Mol. Cancer Res., November 1, 2009; 7(11): 1781 - 1791. [Abstract] [Full Text] [PDF]

				M. Watanabe, G. Yang, G. Cao, S. A. Tahir, K. Naruishi, K.-i. Tabata, E. A. Fattah, K. Rajagopalan, T. L. Timme, S. Park, et al. Functional Analysis of Secreted Caveolin-1 in Mouse Models of Prostate Cancer Progression Mol. Cancer Res., September 1, 2009; 7(9): 1446 - 1455. [Abstract] [Full Text] [PDF]

				D. Di Vizio, J. Kim, M. H. Hager, M. Morello, W. Yang, C. J. Lafargue, L. D. True, M. A. Rubin, R. M. Adam, R. Beroukhim, et al. Oncosome Formation in Prostate Cancer: Association with a Region of Frequent Chromosomal Deletion in Metastatic Disease Cancer Res., July 1, 2009; 69(13): 5601 - 5609. [Abstract] [Full Text] [PDF]

				M. Bastiani, L. Liu, M. M. Hill, M. P. Jedrychowski, S. J. Nixon, H. P. Lo, D. Abankwa, R. Luetterforst, M. Fernandez-Rojo, M. R. Breen, et al. MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes J. Cell Biol., June 29, 2009; 185(7): 1259 - 1273. [Abstract] [Full Text] [PDF]